Site-specific glycan-conjugated NISTmAb antibody drug conjugate mimetics: synthesis, characterization, and utility
- 6 July 2021
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 413 (20) , 4989-5001
Abstract
Antibody drug conjugates (ADCs) represent a rapidly growing modality for the treatment of numerous oncology indications. The complexity of analytical characterization method development is increased due to the potential for synthetic intermediates and process-related impurities. In addition, the cytotoxicity of such materials provides an additional challenge with regard to handling products and/or sharing materials with analytical collaborators and/or vendors for technology development. Herein, we have utilized a site-specific chemoenzymatic glycoconjugation strategy for preparing ADC mimetics composed of the NIST monoclonal antibody (NISTmAb) conjugated to non-cytotoxic payloads representing both small molecules and peptides. The materials were exhaustively characterized with high-resolution mass spectrometry-based approaches to demonstrate the utility of each analytical method for confirming the conjugation fidelity as well as deep characterization of low-abundance synthetic intermediates and impurities arising from payload raw material heterogeneity. These materials therefore represent a widely available test metric to develop novel ADC analytical methods as well as a platform to discuss best practices for extensive characterization.Keywords
This publication has 32 references indexed in Scilit:
- Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeuticsmAbs, 2018
- Measurement of Average Aggregate Density by Sedimentation and Brownian Motion AnalysisJournal of Pharmaceutical Sciences, 2018
- The NISTmAb Reference Material 8671 lifecycle management and quality planAnalytical and Bioanalytical Chemistry, 2018
- Development of orthogonal NISTmAb size heterogeneity control methodsAnalytical and Bioanalytical Chemistry, 2018
- Qualification of NISTmAb charge heterogeneity control assaysAnalytical and Bioanalytical Chemistry, 2018
- Characterization of the NISTmAb Reference Material using small-angle scattering and molecular simulationAnalytical and Bioanalytical Chemistry, 2018
- Characterization of the NISTmAb Reference Material using small-angle scattering and molecular simulationAnalytical and Bioanalytical Chemistry, 2018
- Development of an LC-MS/MS peptide mapping protocol for the NISTmAbAnalytical and Bioanalytical Chemistry, 2018
- The NISTmAb Reference Material 8671 value assignment, homogeneity, and stabilityAnalytical and Bioanalytical Chemistry, 2018
- Multivariate Analysis of Two-Dimensional 1H, 13C Methyl NMR Spectra of Monoclonal Antibody Therapeutics To Facilitate Assessment of Higher Order StructureAnalytical Chemistry, 2017